Lead Product(s): Peptide
Therapeutic Area: Endocrinology Product Name: Undisclosed
Highest Development Status: Preclinical Product Type: Peptide
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable June 26, 2020
The application is directed to new peptides from the company’s two peptide classes, and their use in the treatment of diabetes and its complications.